Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer
Wojciech A. Cieślikowski(Poznan University of Medical Sciences), Joanna Budna(Poznan University of Medical Sciences), Agnieszka Jankowiak(Poznan University of Medical Sciences), Catherine Alix‐Panabières(Université de Montpellier), Klaus Pantel(Universität Hamburg), Andrzej Antczak(Poznan University of Medical Sciences), Michał Kasperczak(Poznan University of Medical Sciences), Piotr Milecki(Poznan University of Medical Sciences), M. Zabel(Poznan University of Medical Sciences), Agnieszka Ida(Poznan University of Medical Sciences), Michał Nowicki(Poznan University of Medical Sciences), Monika Świerczewska(Poznan University of Medical Sciences)
Cited by 13
Related Papers
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
|British Journal of Cancer|2020|402
Hemodynamic Forces Tune the Arrest, Adhesion, and Extravasation of Circulating Tumor Cells
|Developmental Cell|2018|328
Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines
|Journal of Cancer|2016|194